HEADER TRANSFERASE 04-APR-12 4APP TITLE CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH TITLE 2 (S)-N-(5-(3-BENZYL-1-METHYLPIPERAZINE-4-CARBONYL)-6,6-DIMETHYL-1,4,5, TITLE 3 6-TETRAHYDROPYRROLO(3,4-C)PYRAZOL-3-YL)-3-PHENOXYBENZAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PAK 4; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 300-591; COMPND 5 SYNONYM: P21-ACTIVATED KINASE 4, PAK-4; COMPND 6 EC: 2.7.1.37; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: S474 IS PHOSPHORYLATED SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE, PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR D.D.KNIGHTON,Y.L.DENG,C.WANG,C.GUO,I.MCALPINE,J.ZHANG,S.KEPHART, AUTHOR 2 M.C.JOHNSON,H.LI,D.BOUZIDA,A.YANG,L.DONG,J.MARAKOVITS,J.TIKHE, AUTHOR 3 P.RICHARDSON,L.C.GUO,R.KANIA,M.P.EDWARDS,E.KRAYNOV,J.CHRISTENSEN, AUTHOR 4 J.PIRAINO,J.LEE,E.DAGOSTINO,C.DEL-CARMEN,T.SMEAL,B.W.MURRAY REVDAT 3 23-OCT-24 4APP 1 REMARK LINK REVDAT 2 08-MAY-19 4APP 1 REMARK LINK REVDAT 1 06-JUN-12 4APP 0 JRNL AUTH C.GUO,I.MCALPINE,J.ZHANG,D.D.KNIGHTON,S.KEPHART,M.C.JOHNSON, JRNL AUTH 2 H.LI,D.BOUZIDA,A.YANG,L.DONG,J.MARAKOVITS,J.TIKHE, JRNL AUTH 3 P.RICHARDSON,L.C.GUO,R.KANIA,M.P.EDWARDS,E.KRAYNOV, JRNL AUTH 4 J.CHRISTENSEN,J.PIRAINO,J.LEE,E.DAGOSTINO,C.DEL-CARMEN, JRNL AUTH 5 Y.L.DENG,T.SMEAL,B.W.MURRAY JRNL TITL DISCOVERY OF PYRROLOAMINOPYRAZOLES AS NOVEL PAK INHIBITORS. JRNL REF J.MED.CHEM. V. 55 4728 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22554206 JRNL DOI 10.1021/JM300204J REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 350246.480 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 14250 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT : 433 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2071 REMARK 3 BIN R VALUE (WORKING SET) : 0.2290 REMARK 3 BIN FREE R VALUE : 0.2600 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 64 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.032 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2311 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 182 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.38000 REMARK 3 B22 (A**2) : -5.30000 REMARK 3 B33 (A**2) : 6.68000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.21 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.24 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.750 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.260 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.970 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.080 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.960 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.39 REMARK 3 BSOL : 40.43 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4APP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-APR-12. REMARK 100 THE DEPOSITION ID IS D_1290051862. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-03 REMARK 200 TEMPERATURE (KELVIN) : 92 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15002 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.30000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE GROWN FROM THE HANGING REMARK 280 DROP VAPOR DIFFUSION METHOD AT 21 DEGREES CELCIUS BY MIXING 3.6 REMARK 280 MICROLITERS OF A 10 MG/ML PROTEIN SOLUTION WITH A RESERVIOR REMARK 280 SOLUTION CONTAINING: 5% (W/V) MEPEG 5K, 0.1 M IMIDAZOLE AT PH REMARK 280 6.2, 0.1 M (NH4)2HPO4 AND 5MM DTT, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.71200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.91450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.49750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.91450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.71200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.49750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 296 REMARK 465 SER A 297 REMARK 465 HIS A 298 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 591 CA C O CB CG CD NE REMARK 470 ARG A 591 CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 336 CA - CB - SG ANGL. DEV. = 7.9 DEGREES REMARK 500 LYS A 345 CA - CB - CG ANGL. DEV. = 13.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 323 63.35 30.67 REMARK 500 THR A 332 26.91 -159.25 REMARK 500 ASP A 440 42.18 -144.20 REMARK 500 PRO A 479 -72.11 -23.87 REMARK 500 ASN A 537 46.71 -89.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE N53 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2BVA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 REMARK 900 RELATED ID: 2CDZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX REMARK 900 WITH CGP74514A REMARK 900 RELATED ID: 2J0I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 REMARK 900 RELATED ID: 2X4Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX REMARK 900 WITH PF-03758309 DBREF 4APP A 300 591 UNP O96013 PAK4_HUMAN 300 591 SEQADV 4APP GLY A 296 UNP O96013 EXPRESSION TAG SEQADV 4APP SER A 297 UNP O96013 EXPRESSION TAG SEQADV 4APP HIS A 298 UNP O96013 EXPRESSION TAG SEQADV 4APP MET A 299 UNP O96013 EXPRESSION TAG SEQRES 1 A 296 GLY SER HIS MET SER HIS GLU GLN PHE ARG ALA ALA LEU SEQRES 2 A 296 GLN LEU VAL VAL ASP PRO GLY ASP PRO ARG SER TYR LEU SEQRES 3 A 296 ASP ASN PHE ILE LYS ILE GLY GLU GLY SER THR GLY ILE SEQRES 4 A 296 VAL CYS ILE ALA THR VAL ARG SER SER GLY LYS LEU VAL SEQRES 5 A 296 ALA VAL LYS LYS MET ASP LEU ARG LYS GLN GLN ARG ARG SEQRES 6 A 296 GLU LEU LEU PHE ASN GLU VAL VAL ILE MET ARG ASP TYR SEQRES 7 A 296 GLN HIS GLU ASN VAL VAL GLU MET TYR ASN SER TYR LEU SEQRES 8 A 296 VAL GLY ASP GLU LEU TRP VAL VAL MET GLU PHE LEU GLU SEQRES 9 A 296 GLY GLY ALA LEU THR ASP ILE VAL THR HIS THR ARG MET SEQRES 10 A 296 ASN GLU GLU GLN ILE ALA ALA VAL CYS LEU ALA VAL LEU SEQRES 11 A 296 GLN ALA LEU SER VAL LEU HIS ALA GLN GLY VAL ILE HIS SEQRES 12 A 296 ARG ASP ILE LYS SER ASP SER ILE LEU LEU THR HIS ASP SEQRES 13 A 296 GLY ARG VAL LYS LEU SER ASP PHE GLY PHE CYS ALA GLN SEQRES 14 A 296 VAL SER LYS GLU VAL PRO ARG ARG LYS SEP LEU VAL GLY SEQRES 15 A 296 THR PRO TYR TRP MET ALA PRO GLU LEU ILE SER ARG LEU SEQRES 16 A 296 PRO TYR GLY PRO GLU VAL ASP ILE TRP SER LEU GLY ILE SEQRES 17 A 296 MET VAL ILE GLU MET VAL ASP GLY GLU PRO PRO TYR PHE SEQRES 18 A 296 ASN GLU PRO PRO LEU LYS ALA MET LYS MET ILE ARG ASP SEQRES 19 A 296 ASN LEU PRO PRO ARG LEU LYS ASN LEU HIS LYS VAL SER SEQRES 20 A 296 PRO SER LEU LYS GLY PHE LEU ASP ARG LEU LEU VAL ARG SEQRES 21 A 296 ASP PRO ALA GLN ARG ALA THR ALA ALA GLU LEU LEU LYS SEQRES 22 A 296 HIS PRO PHE LEU ALA LYS ALA GLY PRO PRO ALA SER ILE SEQRES 23 A 296 VAL PRO LEU MET ARG GLN ASN ARG THR ARG MODRES 4APP SEP A 474 SER PHOSPHOSERINE HET SEP A 474 10 HET N53 A 601 42 HET GOL A 602 6 HETNAM SEP PHOSPHOSERINE HETNAM N53 N-[6,6-DIMETHYL-5-[(2S)-4-METHYL-2-(PHENYLMETHYL) HETNAM 2 N53 PIPERAZIN-1-YL]CARBONYL-2,4-DIHYDROPYRROLO[3,4- HETNAM 3 N53 C]PYRAZOL-3-YL]-3-PHENOXY-BENZAMIDE HETNAM GOL GLYCEROL HETSYN SEP PHOSPHONOSERINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 SEP C3 H8 N O6 P FORMUL 2 N53 C33 H36 N6 O3 FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *182(H2 O) HELIX 1 1 SER A 300 VAL A 312 1 13 HELIX 2 2 ASP A 316 SER A 319 5 4 HELIX 3 3 ARG A 355 GLN A 357 5 3 HELIX 4 4 ARG A 359 ARG A 371 1 13 HELIX 5 5 LEU A 403 THR A 408 1 6 HELIX 6 6 ASN A 413 GLN A 434 1 22 HELIX 7 7 LYS A 442 ASP A 444 5 3 HELIX 8 8 THR A 478 MET A 482 5 5 HELIX 9 9 ALA A 483 SER A 488 1 6 HELIX 10 10 PRO A 494 GLY A 511 1 18 HELIX 11 11 PRO A 519 ASN A 530 1 12 HELIX 12 12 ASN A 537 VAL A 541 5 5 HELIX 13 13 SER A 542 LEU A 553 1 12 HELIX 14 14 THR A 562 LEU A 567 1 6 HELIX 15 15 LYS A 568 ALA A 575 5 8 HELIX 16 16 PRO A 577 ILE A 581 5 5 HELIX 17 17 ILE A 581 MET A 585 5 5 HELIX 18 18 MET A 585 ARG A 589 5 5 SHEET 1 AA 5 LEU A 321 GLY A 330 0 SHEET 2 AA 5 GLY A 333 VAL A 340 -1 O GLY A 333 N GLY A 330 SHEET 3 AA 5 LEU A 346 ASP A 353 -1 O VAL A 347 N ALA A 338 SHEET 4 AA 5 GLU A 390 MET A 395 -1 O LEU A 391 N MET A 352 SHEET 5 AA 5 MET A 381 VAL A 387 -1 N TYR A 382 O VAL A 394 SHEET 1 AB 3 GLY A 401 ALA A 402 0 SHEET 2 AB 3 ILE A 446 LEU A 448 -1 N LEU A 448 O GLY A 401 SHEET 3 AB 3 VAL A 454 LEU A 456 -1 O LYS A 455 N LEU A 447 SHEET 1 AC 2 VAL A 436 ILE A 437 0 SHEET 2 AC 2 ALA A 463 GLN A 464 -1 O ALA A 463 N ILE A 437 LINK C LYS A 473 N SEP A 474 1555 1555 1.33 LINK C SEP A 474 N LEU A 475 1555 1555 1.33 SITE 1 AC1 20 GLN A 309 LEU A 310 GLY A 330 GLY A 333 SITE 2 AC1 20 ILE A 334 VAL A 335 ALA A 348 LYS A 350 SITE 3 AC1 20 GLU A 396 PHE A 397 LEU A 398 GLU A 399 SITE 4 AC1 20 GLY A 401 ASP A 405 ASP A 444 LEU A 447 SITE 5 AC1 20 ASP A 458 ARG A 586 GOL A 602 HOH A2179 SITE 1 AC2 9 GLY A 330 SER A 331 ASP A 440 LYS A 442 SITE 2 AC2 9 PHE A 461 THR A 478 N53 A 601 HOH A2181 SITE 3 AC2 9 HOH A2182 CRYST1 51.424 64.995 85.829 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019446 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015386 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011651 0.00000